250 related articles for article (PubMed ID: 30562858)
1. [Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to date].
Hamanishi J; Mandai M; Konishi I
Nihon Rinsho; 2017 Feb; 75(2):234-244. PubMed ID: 30562858
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.
Menderes G; Hicks C; Black JD; Schwab CL; Santin AD
Expert Opin Biol Ther; 2016 Aug; 16(8):989-1004. PubMed ID: 27070175
[TBL] [Abstract][Full Text] [Related]
3. Current status of cancer immunotherapy for gynecologic malignancies.
Nishio H; Iwata T; Aoki D
Jpn J Clin Oncol; 2021 Feb; 51(2):167-172. PubMed ID: 33244581
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibition in ovarian cancer.
Hamanishi J; Mandai M; Konishi I
Int Immunol; 2016 Jul; 28(7):339-48. PubMed ID: 27055470
[TBL] [Abstract][Full Text] [Related]
5. Immuno-oncology for Gynecologic Malignancies.
How J; Patel A; Jazaeri A
Adv Exp Med Biol; 2020; 1244():149-182. PubMed ID: 32301014
[TBL] [Abstract][Full Text] [Related]
6. Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.
Zamarin D; Jazaeri AA
Gynecol Oncol; 2016 Apr; 141(1):86-94. PubMed ID: 27016233
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research.
Gadducci A; Guerrieri ME
Anticancer Res; 2017 Nov; 37(11):5955-5965. PubMed ID: 29061774
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Herzberg B; Campo MJ; Gainor JF
Oncologist; 2017 Jan; 22(1):81-88. PubMed ID: 27534574
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies.
Ring KL; Pakish J; Jazaeri AA
Cancer J; 2016; 22(2):101-7. PubMed ID: 27111905
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Immune Checkpoint Inhibitor-related Toxicities in Ovarian Cancer: A Series of Case Vignettes.
Johnson C; Jazaeri AA
Clin Ther; 2018 Mar; 40(3):389-394. PubMed ID: 29519715
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for checkpoint inhibition in hematologic malignancies.
Atanackovic D; Luetkens T
Semin Cancer Biol; 2018 Oct; 52(Pt 2):198-206. PubMed ID: 29775689
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
Peng H; He X; Wang Q
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):941-951. PubMed ID: 35751489
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in gynecological cancers: where are we?
Polastro L; Closset C; Kerger J
Curr Opin Oncol; 2020 Sep; 32(5):459-470. PubMed ID: 32675594
[TBL] [Abstract][Full Text] [Related]
15. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
16. Update on immune checkpoint inhibitors in gynecological cancers.
Heong V; Ngoi N; Tan DS
J Gynecol Oncol; 2017 Mar; 28(2):e20. PubMed ID: 28028993
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in Gynecologic Cancers: Are We There Yet?
Pakish JB; Jazaeri AA
Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint blocking antibodies in cancer immunotherapy.
Kyi C; Postow MA
FEBS Lett; 2014 Jan; 588(2):368-76. PubMed ID: 24161671
[TBL] [Abstract][Full Text] [Related]
19. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.
Braschi-Amirfarzan M; Tirumani SH; Hodi FS; Nishino M
Korean J Radiol; 2017; 18(1):42-53. PubMed ID: 28096717
[TBL] [Abstract][Full Text] [Related]
20. Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors.
Grywalska E; Sobstyl M; Putowski L; Roliński J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]